Table 3:

Hazard Ratios for Mortality among Newly Diagnosed Women with Breast Cancer in Lilongwe, Malawi, 2016–2018.

Variable	Unadjusted HR [95% CI]	p-value	Adjusted HR [95% CI]	p-value
Age	1.00 [0.98–1.04]	0.520	1.00 [0.96–1.04]	0.850
HIV+	1.46 [0.61–3.48]	0.401	5.15 [1.58–16.76]	0.006
Stage
II	1 (ref)		1 (ref)
III	3.11 [0.40–24.47]	0.279	1.39 [0.16–11.79]	0.761
IV	10.89 [1.44–82.50]	0.021	8.86 [1.07–73.25]	0.043
Molecular Subtype
Luminal A	1 (ref)		1 (ref)
Luminal B	3.83 [0.78–18.78]	0.098	2.55 [0.47–13.70]	0.276
HER2-enriched	10.17 [1.94–53.48]	0.006	7.46 [1.21–46.07]	0.031
Triple-negative	6.91 [1.42–33.61]	0.017	7.80 [1.39–43.69]	0.020

The adjusted model includes all variables listed above.